These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22479161)

  • 1. Comparison of levalbuterol and racemic albuterol based on cardiac adverse effects in children.
    Bio LL; Willey VJ; Poon CY
    J Pediatr Pharmacol Ther; 2011 Jul; 16(3):191-8. PubMed ID: 22479161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of heart rate changes associated with levalbuterol and racemic albuterol in pediatric cardiology patients.
    Kelly A; Kennedy A; John BM; Duane B; Lemanowicz J; Little J
    Ann Pharmacother; 2013 May; 47(5):644-50. PubMed ID: 23613097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients.
    Gawchik SM; Saccar CL; Noonan M; Reasner DS; DeGraw SS
    J Allergy Clin Immunol; 1999 Apr; 103(4):615-21. PubMed ID: 10200010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in heart rate associated with nebulized racemic albuterol and levalbuterol in intensive care patients.
    Lam S; Chen J
    Am J Health Syst Pharm; 2003 Oct; 60(19):1971-5. PubMed ID: 14531242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
    Berger WE; Milgrom H; Skoner DP; Tripp K; Parsey MV; Baumgartner RA;
    Curr Med Res Opin; 2006 Jun; 22(6):1217-26. PubMed ID: 16846555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma.
    Truitt T; Witko J; Halpern M
    Chest; 2003 Jan; 123(1):128-35. PubMed ID: 12527613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma.
    Nelson HS; Bensch G; Pleskow WW; DiSantostefano R; DeGraw S; Reasner DS; Rollins TE; Rubin PD
    J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):943-52. PubMed ID: 9847435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
    Tripp K; McVicar WK; Nair P; Corren J; Pleskow WW; Goodwin E; Baumgartner RA; Hanrahan JP
    J Allergy Clin Immunol; 2008 Sep; 122(3):544-9. PubMed ID: 18692886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective comparison of nebulized levalbuterol and albuterol for adverse events in patients with acute airflow obstruction.
    Scott VL; Frazee LA
    Am J Ther; 2003; 10(5):341-7. PubMed ID: 12975718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma.
    Pleskow WW; Nelson HS; Schaefer K; Claus R; Roach JM
    Allergy Asthma Proc; 2004; 25(6):429-36. PubMed ID: 15709454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in Oxygen Consumption Following Inhalation of Albuterol in Comparison with Levalbuterol in Healthy Adult Volunteers.
    Virk MK; Hotz J; Khemani RG; Newth CJ; Ross PA
    Lung; 2017 Apr; 195(2):233-239. PubMed ID: 28210808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of racemic albuterol and levalbuterol for treatment of acute asthma.
    Carl JC; Myers TR; Kirchner HL; Kercsmar CM
    J Pediatr; 2003 Dec; 143(6):731-6. PubMed ID: 14657817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.
    Hamilos DL; D'Urzo A; Levy RJ; Marcus M; Tripp K; Parsey M; Baumgartner RA; McVicar WK
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):540-8. PubMed ID: 18219836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient satisfaction survey comparing levalbuterol with racemic albuterol in children.
    Berger WE; Ames DE; Harrison D
    Allergy Asthma Proc; 2004; 25(6):437-44. PubMed ID: 15709455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of nebulized levalbuterol in stable COPD.
    Datta D; Vitale A; Lahiri B; ZuWallack R
    Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma.
    Handley DA; Tinkelman D; Noonan M; Rollins TE; Snider ME; Caron J
    J Asthma; 2000 Jun; 37(4):319-27. PubMed ID: 10883742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED.
    Schreck DM; Babin S
    Am J Emerg Med; 2005 Nov; 23(7):842-7. PubMed ID: 16291438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with levalbuterol.
    Nelson HS
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S77-84. PubMed ID: 10452792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levalbuterol is as effective as racemic albuterol in lowering serum potassium.
    Pancu D; LaFlamme M; Evans E; Reed J
    J Emerg Med; 2003 Jul; 25(1):13-6. PubMed ID: 12865102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.